Logo

OGT Licenses Southern Array Patents to Taiwan's Phalanx Biotech Group

Nov 01, 2007
NEW YORK (GenomeWeb News) ¯ Oxford Gene Technology yesterday said it has granted Phalanx Biotech Group a license to its Southern array patents.
 
The deal enables Taiwan-based Phalanx to sell arrays, including its whole-genome OneArray platform, for gene expression-profile studies in the US.
 
The license is valid for the patents’ lifetime.
 
Financial details were not disclosed.

Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.